Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
AN-1792 AIP 001 Discontinued Janssen, Pfizer Amyloid-Related Immunotherapy (active) Alzheimer's Disease None
Avagacestat BMS-708163 Discontinued Bristol-Myers Squibb Amyloid-Related Small Molecule Alzheimer's Disease
Bapineuzumab AAB-001 Discontinued Janssen, Pfizer Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Flurizan™ tarenflurbil ,
r-flurbiprofen,
MPC-7869
Discontinued Myriad Genetics & Laboratories Amyloid-Related Small Molecule Alzheimer's Disease None
Gammagard™ Intravenous Immunoglobulin,
IVIg
Discontinued Baxter Healthcare Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease Immunodeficiency conditions
LY2886721 β-secretase inhibitor Discontinued, Discontinued Eli Lilly & Co. Amyloid-Related Small Molecule Alzheimer's Disease, Mild Cognitive Impairment
Ponezumab PF-04360365 Discontinued, 2 Pfizer Amyloid-Related Immunotherapy (passive) Alzheimer's Disease, Cerebral Amyloid Angiopathy None
RG7129 RO5508887,
BACE1 Inhibitor
Discontinued Roche Amyloid-Related Small Molecule Alzheimer's Disease
Semagacestat LY450139 Dihydrate ,
hydroxylvaleryl monobenzocaprolactam
Discontinued Eli Lilly & Co. Amyloid-Related Small Molecule Alzheimer's Disease None
Vanutide cridificar ACC-001,
PF-05236806
Discontinued Pfizer Amyloid-Related Immunotherapy (active) Alzheimer's Disease None